- Home
- CTMX vs BBBY Comparison
CTMX vs BBBY Comparison
Compare CTMX & BBBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- BBBY
- Stock Information
- Founded
- CTMX 2008
- BBBY 1971
- Country
- CTMX United States
- BBBY United States
- Employees
- CTMX N/A
- BBBY N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- BBBY
- Sector
- CTMX Health Care
- BBBY
- Exchange
- CTMX Nasdaq
- BBBY Nasdaq
- Market Cap
- CTMX 596.2M
- BBBY 573.5M
- IPO Year
- CTMX 2015
- BBBY N/A
- Fundamental
- Price
- CTMX $3.32
- BBBY $8.39
- Analyst Decision
- CTMX Strong Buy
- BBBY Hold
- Analyst Count
- CTMX 5
- BBBY 1
- Target Price
- CTMX $5.80
- BBBY $8.00
- AVG Volume (30 Days)
- CTMX 3.0M
- BBBY 2.8M
- Earning Date
- CTMX 11-07-2025
- BBBY 10-27-2025
- Dividend Yield
- CTMX N/A
- BBBY N/A
- EPS Growth
- CTMX 263.20
- BBBY N/A
- EPS
- CTMX 0.49
- BBBY N/A
- Revenue
- CTMX $141,100,000.00
- BBBY $1,074,337,000.00
- Revenue This Year
- CTMX N/A
- BBBY N/A
- Revenue Next Year
- CTMX N/A
- BBBY $11.57
- P/E Ratio
- CTMX $6.79
- BBBY N/A
- Revenue Growth
- CTMX 18.01
- BBBY N/A
- 52 Week Low
- CTMX $0.40
- BBBY $3.54
- 52 Week High
- CTMX $3.91
- BBBY $12.65
- Technical
- Relative Strength Index (RSI)
- CTMX 55.87
- BBBY 44.10
- Support Level
- CTMX $3.21
- BBBY $7.99
- Resistance Level
- CTMX $3.91
- BBBY $9.18
- Average True Range (ATR)
- CTMX 0.26
- BBBY 0.73
- MACD
- CTMX -0.06
- BBBY -0.09
- Stochastic Oscillator
- CTMX 30.59
- BBBY 18.88
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About BBBY Bed Bath & Beyond Inc.
Bed Bath & Beyond Inc is an ecommerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering a comprehensive array of products and services that enable its customers to enhance everyday life through quality, style, and value. The Company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites as well as a blockchain asset portfolio.